Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among females, producing symptoms in approximately 5% to 10% of women of reproductive age. Such symptoms should include at least two of three of the following: (1) irregular menstrual cycles, (2) clinical and or biochemical (through laboratory assessment) hyperandrogenism, and (3) polycystic appearing ovaries on ultrasound. Notably, PCOS is generally a diagnosis of exclusion, which means that all other causes for the presenting symptoms should be excluded. Additionally, up to 20% of women without PCOS will have polycystic appearing ovaries on ultrasound.
PCOS has both reproductive and medical consequences to the affected woman. From a reproductive standpoint, the woman may suffer from anovulatory infertility. From a medical standpoint, affected women are at an increased risk for obstructive sleep apnea, depression, insulin resistance, type 2 diabetes, and metabolic syndrome. As such, women with polycystic ovary syndrome should be screened for these outcomes on a regular basis, and treated appropriately.
If identified, your Team RMI physician will treat both the reproductive and metabolic consequences of this disease.